Report copyright - 4- PERRIN S. - ONCOLIE 2015 · 2015-03-31 · DCI–nom commercial Cible Inhibition Indication BevacizumabAVASTIN® VEGF Néo-angiogénèse Sein,rein, ovaires, poumon, colo-rectal
Please pass captcha verification before submit form
Please pass captcha verification before submit form